Advocacy intelligence hub — real-time data for patient organizations
Vima Therapeutics — PHASE2
University of Maryland, Baltimore — NA
MGH Institute of Health Professions — NA
National Institute of Neurological Disorders and Stroke (NINDS) — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Mark Hallett, M.D., MD
National Institute of Neurological Disorders and Stroke (NINDS)
📍 APPLETON, WI
Kenneth H Fischbeck, M.D., M.D
National Institute of Neurological Disorders and Stroke (NINDS)
📍 BETHESDA, MD
David M Simpson, MD
Icahn School of Medicine at Mount Sinai
Debra J Ehrlich, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
📍 GLENDALE, AZ
Noreen Bukhari-Parlakturk, MD PhD, MD, PhD
Duke Health
📍 STONY BROOK, NY
David Simpson, MD
Icahn School of Medicine at Mount Sinai
View all Focal, segmental or multifocal dystonia specialists →